Interested in the latest breast cancer clinical trial updates and how new approaches to treatment will be incorporated into care for Canadian patients? We are bringing 20 people from the breast cancer community to the Canadian Breast Cancer Symposium (CBCS) this year!
The Canadian Breast Cancer Symposium (CBCS) is a national multidisciplinary medical conference for healthcare professionals in Canada who treat people with breast cancer. It is taking place June 19-20, 2025, at The Hilton Downtown Toronto.
After approaching the CBCS chairs in 2017 about integrating patient participation into this medical conference, Rethink Breast Cancer got the green light to take it on. Since 2019, our role has been ensuring the breast cancer community is represented at the conference, from sharing patient experiences at the podium in keynote and panel discussions to supporting people with breast cancer to be active participants at the conference. Our Executive Director and Founder, MJ DeCoteau is also a member of the CBCS Faculty!
At Rethink, we believe the voices and values of people with breast cancer should be incorporated wherever decision about care and treatment are made. This is exactly why we think it’s important for those with lived experience to be a part of this conference and continue to partner with CBCS year after year.
While this is a conference for the medical community, we are excited to bring 20 people from the breast cancer community to the symposium again this year! It is a unique opportunity to hear latest clinical trial updates, learn from clinical experts from across the multidisciplinary treatment of breast cancer in Canada and connect with others connected to the cause.
Canadian Breast Cancer Symposium 2025
June 19 + 20 (Attendees must be able to be at the conference both days, plus join a Rethink-led online prep session ahead of the conference).
Hilton Downtown Toronto (Attendees will be responsible for their travel and accommodations).
If you are someone who has a personal experience with breast cancer and are interested in attending CBCS 2025, please fill out the form below. Applications are open from April 16, 2025 until April 30, 2025. Invited attendees will be notified by May 14, 2025.
By applying for and accepting a spot to attend CBCS 2025, you agree to:
1. Attend a Rethink-led online preparation session in advance of the symposium
2. Attend the entire 2-day symposium
3. After the symposium, contribute to a form of knowledge sharing with the breast cancer community depending on your interest and capacity.
This could look a few different ways, including: sharing about the symposium, your key takeaways and experience on social media, tagging Rethink; writing a blog post (an example from a past attendee) for Rethink’s blog about a specific topic relevant to the symposium, a session or study that has stuck with you; sharing a testimonial with Rethink about your experience attending the conference to be used in Rethink’s presentations, website, social media, etc.).
How you choose to contribute in knowledge sharing post-conference is up to you and can be decided after the conference. We’ll be in touch about this post-conference to remind you and share ideas!
Key topics for this year are:
• Lobular Breast Cancer
• Liquid Biopsies and Circulating Tumour DNA (ctDNA)
• Surgical Resections for Metastatic Disease
• Surgical Advances in Lymphedema
• Latest Data and Research in Survivorship
Please feel free to email us at hello@rethinkbreastcancer.com with “CBCS 2025” in the subject line. We’re happy to answer your questions!